Logos Global Management LP Silence Therapeutics PLC Transaction History
Logos Global Management LP
- $1.07 Billion
- Q1 2024
A detailed history of Logos Global Management LP transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Logos Global Management LP holds 1,476,061 shares of SLN stock, worth $28 Million. This represents 2.97% of its overall portfolio holdings.
Number of Shares
1,476,061
Previous 400,000
269.02%
Holding current value
$28 Million
Previous $6.95 Million
358.87%
% of portfolio
2.97%
Previous 0.74%
Shares
2 transactions
Others Institutions Holding SLN
# of Institutions
63Shares Held
27.1MCall Options Held
0Put Options Held
0-
Tcg Crossover Management, LLC Palo Alto, CA3.3MShares$62.6 Million7.49% of portfolio
-
Artal Group S.A. Luxembourg, N42.78MShares$52.8 Million3.24% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY2.39MShares$45.4 Million1.25% of portfolio
-
Lombard Odier Asset Management (Europe) LTD London, X02.24MShares$42.5 Million4.48% of portfolio
-
Redmile Group, LLC San Francisco, CA2.03MShares$38.5 Million1.73% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $682M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...